December 22, 2023
One Doctor’s Fight for COVID Justice
By
Larry Kaifesh
A physician with more than 25 years of experience, Dr. Mary Talley Bowden is board-certified in otolaryngology and sleep medicine. In 2019, she founded BreatheMD in Houston. Educated at the University of North Carolina in Chapel Hill, the Medical College of Georgia at Augusta University, and the University of Texas Medical Branch, Dr. Bowden completed her residency at Stanford University. She is one of the few direct care specialists in the U.S. who does not contract with any health insurance companies and strives to offer affordable care with clear pricing.
Dr. Bowden was targeted after speaking out against prescribed protocols for treating COVID-19 and the experimental COVID vaccine. She has been a target of the Texas Medical Board, the U.S. Food and Drug Administration, and Houston Methodist Hospital for her early treatment of over 6,000 patients with COVID-19, despite her record including no deaths.
Her results highlight the effectiveness of her protocol in direct contrast to the protocols hospitals were using. The hospital protocols are using are connected with countless deaths, hospitalizations, and adverse effects, according to the government data found on the Vaccine Adverse Event Reporting System (VAERS).
Following Dr. Bowden’s success with her protocols, the Texas Medical Board filed a formal complaint against her for violations of the Texas Medical Practice Act. Now, after a couple of appeals, her next hearing is scheduled to take place April 29, 2024.
From early on in the pandemic, Dr. Bowden, and other doctors, were using ivermectin, the Nobel Prize–winning medication, in their extremely effective treatment protocols. In response, the FDA initiated an aggressive campaign against using ivermectin in treating COVID-19. The FDA used the famous “horse” message stating, “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19,” emphasizing that it is a horse dewormer and should not be used on people. This message can still be found on the
FDA website.